|
KMID : 0948920200190010032
|
|
Clinical Pain
2020 Volume.19 No. 1 p.32 ~ p.35
|
|
|
Treatment-Induced Neuropathy of Diabetes
|
|
Kim Kee-Hoon
Leem Min-Jeong
Yi Tae-Im
Kim Joo-Sup
Yoon Seo-Yeon
|
|
|
Abstract
|
|
|
|
Treatment-induced neuropathy in diabetes (TIND) is a reversible neuropathy that occurs in patients with diabetes, usually after a fast improvement in glycemic control. TIND is defined as the sudden onset of neuropathic pain or autonomic dysfunction with a large improvement in glycemic control (glycated hemoglobin [HbA1c] level of ≥ 2% over 3 months). We report the first case of a 24-year-old woman with type 1 diabetes mellitus who developed TIND in Korea. Her HbA1c level had decreased from 16.7% to 7.3% within a 3-month period. She developed acute-onset, severe, and continuous burning pain affecting her back and lower extremities. She was administered tapentadol (50 mg), pregabalin (75 mg), and vitamin B with minerals twice daily for neuropathic pain. She complained of orthostatic hypotension; thus, midodrine (2.5 mg) and anti-embolic stockings were prescribed. She almost completely recovered 6 months after the onset. A physician should be aware of TIND and gradually reduce HbA1c levels to prevent the occurrence of TIDN. They must also try to provide relief from severe pain or autonomic dysfunction and emphasize on an almost complete recovery.
|
|
|
KEYWORD
|
|
|
Diabetes mellitus, Neuropathy, Autonomic dysfunction, Neuropathic pain, Orthostatic hypotension
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|